Eledon reports inducement grants under nasdaq listing rule 5635(c)(4)

Irvine, calif., feb. 13, 2024 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today announced that the company's compensation committee granted 42,500 restricted stock units (rsus) and stock options to purchase an aggregate of 90,000 common shares, at a per share exercise price of $1.77, the closing price of eledon's common stock on the grant date, to one employee.
ELDN Ratings Summary
ELDN Quant Ranking